Clinical trials
Completed Escherichia coli Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NIZO Food Research | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| U.S. Army Medical Research and Development Command | 3 |
| University of Pittsburgh | 3 |
| Bausch Health Americas, Inc. | 2 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| Medical University of Vienna | 2 |
| PATH | 2 |
| US Department of Veterans Affairs | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Escherichia coli Infections | 57 |
| Diarrhea | 15 |
| Urinary Tract Infections | 11 |
| Bacterial Infections | 7 |
| Gastroenteritis | 5 |
| Enteritis | 3 |
| Infections | 3 |
| Klebsiella Infections | 3 |
| Spinal Cord Injuries | 3 |
| Dysentery, Bacillary | 2 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.